Wolfe Research initiated coverage of Vera Therapeutics (VERA) with an Outperform rating.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERA:
- 3 Best Stocks to Buy Now, 1/29/2025, According to Top Analysts
- Vera Therapeutics initiated with a Buy at Goldman Sachs
- 3 Best Stocks to Buy Now, 1/17/2025, According to Top Analysts
- Vera Therapeutics Highlights Atacicept Progress at Conference
- Vera Therapeutics acquires global rights to next-gen dual BAFF/APRIL inhibitor